Clinical trial · Interventional
Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs
A Multicenter, Randomized, Controlled Trial of the Effective Therapy for Multiple, Small Hepatocellular Carcinomas: Comparing Transarterial Chemoembolization With Percutaneous Ethanol Injection Therapy.
NCT00357474CI-TRIAL-00012808completedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to choose the preferred treatment modality for multiple, small hepatocellular carcinomas.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Percutaneous ethanol injection therapy | Procedure | — | UNRESOLVED |
| Transarterial chemoembolization | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- chemotherapy
- description
- Transarterial chemoembolization (TACE)
- interventionNames
- Procedure: Transarterial chemoembolization
- type
- ACTIVE_COMPARATOR
- label
- ethanol
- description
- Percutaneous ethanol injection therapy (PEIT)
- interventionNames
- Procedure: Percutaneous ethanol injection therapy
Primary outcomes (1)
- measure
- overall survival rate
- timeFrame
- 5 year
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * The evidences of HBV(+) \&/or HCV(+) infection or liver cirrhosis * Two to three tumor nodules with Child-Pugh classification A or single to three tumor nodules with Child-Pugh classification B * The maximal, longest diameter of tumor mass measured by CT finding should be less than 2 cm. * 1\) Only for newly detected HCCs which were not treated before or 2) If treated before, it should be noted that there is no evidence of recurrence within the latest 6 months and, and also it should be remotely recurred more than 2cm apart from primary lesion. * It should be compatible with the typical findings of HCCs radiologically(MD CT or dynamic MRI) Exclusion Criteria: * In case of hepatic vein or portal vein invasion radiologically(CT or MRI)
References
Publications (0)
Data not yet available
No reference posted for this study.